Categories AlphaGraphs, Earnings, Health Care

Key highlights from Biogen’s (BIIB) Q4 2022 earnings results

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today.

Total revenue fell 7% year-over-year to $2.54 billion.

Net income attributable to Biogen Inc. was $550.4 million, or $3.79 per share, compared to $368.2 million, or $2.50 per share, last year. Adjusted EPS rose 19% to $4.05.

Both the top and bottom line numbers beat expectations.

For the full year of 2023, adjusted EPS is expected to range between $15.00-16.00.

Prior performance

Biogen Q3 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Infographic: How Lennar (LEN) performed in Q4 2025

Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the fourth quarter of 2025, compared to $9.9 billion reported in the same period a year ago. Net earnings

Paychex expected to report higher revenue and earnings for Q2 FY26

Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the

Signet Jewelers (SIG): A look at the progress made on Grow Brand Love

Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top